Investigator's Brochure (IB) Table

Drugs

Drug Name Sort descending Drug Company IB Date Risk List Available?
ABT-267, ABT 333, ABT-450 and Ritonavir AbbVie June 2017
Bedaquiline (TMC207) Janssen Research & Development October 2019
Cemiplimab (REGN2810) Regeneron Pharmaceuticals, Inc. June 2020
Cenicriviroc Mesylate CVC (TBR-652) Allergan March 2020
Dapivirine (Microbicide Gel) International Partnership for Microbicides May 2017
Dapivirine (Vaginal Ring) International Partnership For Microbicides November 2019
Delamanid (OPC-67683) Otsuka April 2020
Dolutegravir (GSK1349572) ViiV Healthcare September 2020
Doravirine (MK-1439) Merck January 2020
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (MK-1439A) Merck January 2020
Emtricitabine/Tenofovir Disoproxil Fumarate (Truvada) Gilead Sciences December 2016 YES
Etravirine (TMC125, Intelence) Janssen Research & Development November 2019
Glecaprevir (ABT-493) and Pibrentasvir (ABT-530) AbbVie December 2018
GSK1265744 (Cabotegravir) ViiV Healthcare December 2019
Maraviroc (UK-427857) ViiV Healthcare December 2020
PC-1005 Population Council April 2017
Raltegravir (Isentress) Merck September 2017 YES
Rifapentine Sanofi August 2013
Rilpivirine (TMC278, Edurant) Janssen Research & Development July 2020
Sofosbuvir/Velapatasvir (Epclusa) Gilead July 2016